Christoph Berger - Infectious Diseases

Author Information

Christoph Berger is a prominent researcher affiliated with the Division of Infectious Diseases and Hospital Epidemiology at the University Children's Hospital Zurich in Switzerland. His expertise lies in the field of infectious diseases, with a strong focus on pediatric populations. Berger's work often intersects with areas such as epidemiology, clinical pharmacology, and public health, contributing significantly to our understanding of infectious diseases and their impact on various populations.

Research Contributions

Christoph Berger has made substantial contributions to the field of infectious diseases through a variety of research endeavors. His recent studies have covered topics ranging from the effects of COVID-19 vaccinations on clinical imaging, to pediatric pharmacokinetics, and the challenges of managing infections in immunocompromised patients such as solid organ transplant recipients. Notably, his work includes insights into the evolution of COVID-19 mortality, best practices for managing pediatric inflammatory syndromes associated with SARS-CoV-2, and the standardization of hospital records to advance pediatric research. Berger's research often highlights the nuances of infectious disease management in children and the importance of tailored healthcare approaches.

Aliases

Christoph Berger is also known by several aliases, including C. Berger, C Berger, and Ch. Berger. These variations are frequently used in academic publications and databases.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	210
Total Citation Count	5122
H-index	39

Publications:

Frequency and intensity of [18F]-PSMA-1007 uptake after COVID-19 vaccination in clinical PET

DOI: 10.1259/bjro.20210084

Year: 2022

Fetal-Maternal Surgery for Spina Bifida in a HIV-Infected Mother

DOI: 10.1159/000521788

Year: 2022

Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)

DOI: 10.1101/2021.09.14.21263153

Year: 2021

Gentamicin Population Pharmacokinetics in Pediatric Patients—A Prospective Study with Data Analysis Using the saemix Package in R

DOI: 10.3390/pharmaceutics13101596

Year: 2021

SwissPedData: Standardising hospital records for the benefit of paediatric research.

DOI: 10.4414/smw.2021.w30069

Year: 2021

Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients

DOI: 10.1111/ajt.16831

Year: 2021

Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs

DOI: 10.3390/microorganisms9081700

Year: 2021

Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis

DOI: 10.1007/s00262-020-02835-x

Year: 2021

Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland

DOI: 10.3389/fped.2021.667507

Year: 2021

Prediction of Past SARS-CoV-2 Infections: A Prospective Cohort Study Among Swiss Schoolchildren

DOI: 10.3389/fped.2021.710785

Year: 2021

What are the Symptoms of Ebola?

What Challenges Does the RBM Partnership Face?

What is Dengue?

What Is the Future of Research on Respiratory Droplets?

How is Pink Eye Diagnosed?

What are Pediatric Infectious Diseases?

What is Proteomics?

How do Infectious Diseases Spread?

What Are the Side Effects of Antimalarial Drugs?

How Do X-rays Assist in Diagnosing Infections?

Partnered Content Networks

Relevant Topics